Archive for May 7th, 2012

INSM clinical hold lifted. VVUS MAA decision due 2Q. Updates for ANX BCRX KERX PSDV SGEN TZYM PBTH

May 07, 2012 No Comments by

Insmed Incorporated (Nasdaq CM: INSM) today announced the FDA lifted the clinical hold previously placed on ARIKACE in Cystic Fibrosis (CF) patients with Pseudomonas lung infections. ADVENTRX Pharmaceuticals, Inc.(NYSE Amex: ANX) today said that its product ANX-188 is expected to be initiated in a Phase 3 trial in patients with sickle cell disease, later in 2012. VIVUS, Inc. (NASDAQ: VVUS) […]

Daily News Read more